UBS AM’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-35,729
| Closed | -$4.71M | – | 2846 |
|
|
2018
Q4 | $4.71M | Buy |
35,729
+1,666
| +5% | +$213K | ﹤0.01% | 1113 |
|
|
2018
Q3 | $4.55M | Sell |
34,063
-104
| -0.3% | -$15.6K | ﹤0.01% | 1177 |
|
|
2018
Q2 | $5.44M | Buy |
34,167
+518
| +2% | +$76.8K | ﹤0.01% | 1120 |
|
|
2018
Q1 | $4.81M | Buy |
33,649
+4,640
| +16% | +$634K | ﹤0.01% | 1163 |
|
|
2017
Q4 | $3.86M | Sell |
29,009
-3,591
| -11% | -$459K | ﹤0.01% | 1195 |
|
|
2017
Q3 | $4.05M | Buy |
32,600
+2,064
| +7% | +$284K | ﹤0.01% | 1161 |
|
|
2017
Q2 | $4.29M | Buy |
30,536
+7,605
| +33% | +$950K | ﹤0.01% | 1081 |
|
|
2017
Q1 | $2.58M | Buy |
22,931
+2,820
| +14% | +$329K | ﹤0.01% | 1246 |
|
|
2016
Q4 | $2.12M | Sell |
20,111
-10,406
| -34% | -$1.12M | ﹤0.01% | 1268 |
|
|
2016
Q3 | $3.85M | Buy |
30,517
+2,043
| +7% | +$260K | ﹤0.01% | 1120 |
|
|
2016
Q2 | $3.93M | Buy |
28,474
+685
| +2% | +$90.6K | ﹤0.01% | 1087 |
|
|
2016
Q1 | $3.86M | Sell |
27,789
-4,324
| -13% | -$593K | ﹤0.01% | 1107 |
|
|
2015
Q4 | $5.17M | Buy |
32,113
+795
| +3% | +$123K | 0.01% | 1065 |
|
|
2015
Q3 | $4.18M | Buy |
31,318
+6,419
| +26% | +$837K | ﹤0.01% | 1123 |
|
|
2015
Q2 | $2.85M | Buy |
24,899
+2,100
| +9% | +$251K | ﹤0.01% | 1243 |
|
|
2015
Q1 | $2.72M | Buy |
22,799
+1,800
| +9% | +$240K | ﹤0.01% | 1233 |
|
|
2014
Q4 | $3.06M | Buy |
20,999
+900
| +4% | +$113K | ﹤0.01% | 1177 |
|
|
2014
Q3 | $2.65M | Hold |
20,099
| – | – | ﹤0.01% | 1212 |
|
|
2014
Q2 | $2.52M | Buy |
20,099
+3,800
| +23% | +$491K | ﹤0.01% | 1244 |
|
|
2014
Q1 | $2.61M | Buy |
16,299
+1,700
| +12% | +$280K | ﹤0.01% | 1224 |
|
|
2013
Q4 | $1.96M | Buy |
14,599
+200
| +1% | +$25.7K | ﹤0.01% | 1283 |
|
|
2013
Q3 | $1.56M | Hold |
14,399
| – | – | ﹤0.01% | 1331 |
|
|
2013
Q2 | $1.22M | Buy |
+14,399
| New | +$1.29M | ﹤0.01% | 1373 |
|
UBS AM's ATHN Position: Q1 2019 in Review
UBS AM sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 35,729 shares — an estimated $4.71M sold.
UBS AM first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $5.44M in Q2 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- UBS AM reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- UBS AM sold 35,729 Athenahealth, Inc. shares in Q1 2019, an estimated $4.71M.
- UBS AM first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
- UBS AM's Athenahealth, Inc. position peaked at $5.44M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on UBS AM's 13F filing for Q1 2019, filed 14 May 2019.